Fenofibrate reduces C-reactive protein levels in hypertriglyceridemic patients with high risks for cardiovascular diseases.

Korean Circ J · 2012 · PMC3518707 · PMID 23236325

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

borderline significancep=0.097so close (0.05 < p ≤ 0.1)

CRP levels decreased more in the fenofibrate group than in the comparison group in patients with a BMI ≤26 kg/m 2 with borderline significance (-1.21±1.82 mg/L vs. -0.89±1.92 mg/L, p=0.097).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.